Table of Content

1 Nonnarcotic Analgesics Market Overview
1.1 Product Overview and Scope of Nonnarcotic Analgesics
1.2 Nonnarcotic Analgesics Segment by Type
1.2.1 Global Nonnarcotic Analgesics Market Value Comparison by Type (2024-2034)
1.2.2 Salicylates
1.2.3 Anilines
1.2.4 Pyrazolones
1.2.5 Other
1.3 Nonnarcotic Analgesics Segment by Application
1.3.1 Global Nonnarcotic Analgesics Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Specialist Clinic
1.3.5 Other
1.4 Global Nonnarcotic Analgesics Market Size Estimates and Forecasts
1.4.1 Global Nonnarcotic Analgesics Revenue 2018-2029
1.4.2 Global Nonnarcotic Analgesics Sales 2018-2029
1.4.3 Global Nonnarcotic Analgesics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nonnarcotic Analgesics Market Competition by Manufacturers
2.1 Global Nonnarcotic Analgesics Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nonnarcotic Analgesics Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nonnarcotic Analgesics Average Price by Manufacturers (2018-2024)
2.4 Global Nonnarcotic Analgesics Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nonnarcotic Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nonnarcotic Analgesics, Product Type & Application
2.7 Nonnarcotic Analgesics Market Competitive Situation and Trends
2.7.1 Nonnarcotic Analgesics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nonnarcotic Analgesics Players Market Share by Revenue
2.7.3 Global Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nonnarcotic Analgesics Retrospective Market Scenario by Region
3.1 Global Nonnarcotic Analgesics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nonnarcotic Analgesics Global Nonnarcotic Analgesics Sales by Region: 2018-2029
3.2.1 Global Nonnarcotic Analgesics Sales by Region: 2018-2024
3.2.2 Global Nonnarcotic Analgesics Sales by Region: 2024-2029
3.3 Global Nonnarcotic Analgesics Global Nonnarcotic Analgesics Revenue by Region: 2018-2029
3.3.1 Global Nonnarcotic Analgesics Revenue by Region: 2018-2024
3.3.2 Global Nonnarcotic Analgesics Revenue by Region: 2024-2029
3.4 North America Nonnarcotic Analgesics Market Facts & Figures by Country
3.4.1 North America Nonnarcotic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nonnarcotic Analgesics Sales by Country (2018-2029)
3.4.3 North America Nonnarcotic Analgesics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nonnarcotic Analgesics Market Facts & Figures by Country
3.5.1 Europe Nonnarcotic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nonnarcotic Analgesics Sales by Country (2018-2029)
3.5.3 Europe Nonnarcotic Analgesics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nonnarcotic Analgesics Market Facts & Figures by Country
3.6.1 Asia Pacific Nonnarcotic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nonnarcotic Analgesics Sales by Country (2018-2029)
3.6.3 Asia Pacific Nonnarcotic Analgesics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nonnarcotic Analgesics Market Facts & Figures by Country
3.7.1 Latin America Nonnarcotic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nonnarcotic Analgesics Sales by Country (2018-2029)
3.7.3 Latin America Nonnarcotic Analgesics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nonnarcotic Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Nonnarcotic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nonnarcotic Analgesics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nonnarcotic Analgesics Sales by Type (2018-2029)
4.1.1 Global Nonnarcotic Analgesics Sales by Type (2018-2024)
4.1.2 Global Nonnarcotic Analgesics Sales by Type (2024-2029)
4.1.3 Global Nonnarcotic Analgesics Sales Market Share by Type (2018-2029)
4.2 Global Nonnarcotic Analgesics Revenue by Type (2018-2029)
4.2.1 Global Nonnarcotic Analgesics Revenue by Type (2018-2024)
4.2.2 Global Nonnarcotic Analgesics Revenue by Type (2024-2029)
4.2.3 Global Nonnarcotic Analgesics Revenue Market Share by Type (2018-2029)
4.3 Global Nonnarcotic Analgesics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nonnarcotic Analgesics Sales by Application (2018-2029)
5.1.1 Global Nonnarcotic Analgesics Sales by Application (2018-2024)
5.1.2 Global Nonnarcotic Analgesics Sales by Application (2024-2029)
5.1.3 Global Nonnarcotic Analgesics Sales Market Share by Application (2018-2029)
5.2 Global Nonnarcotic Analgesics Revenue by Application (2018-2029)
5.2.1 Global Nonnarcotic Analgesics Revenue by Application (2018-2024)
5.2.2 Global Nonnarcotic Analgesics Revenue by Application (2024-2029)
5.2.3 Global Nonnarcotic Analgesics Revenue Market Share by Application (2018-2029)
5.3 Global Nonnarcotic Analgesics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GlaxoSmithKline Consumer Healthcare
6.1.1 GlaxoSmithKline Consumer Healthcare Corporation Information
6.1.2 GlaxoSmithKline Consumer Healthcare Description and Business Overview
6.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product Portfolio
6.1.5 GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
6.2 Bayer Corporation
6.2.1 Bayer Corporation Corporation Information
6.2.2 Bayer Corporation Description and Business Overview
6.2.3 Bayer Corporation Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bayer Corporation Nonnarcotic Analgesics Product Portfolio
6.2.5 Bayer Corporation Recent Developments/Updates
6.3 Atnahs Pharma
6.3.1 Atnahs Pharma Corporation Information
6.3.2 Atnahs Pharma Description and Business Overview
6.3.3 Atnahs Pharma Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Atnahs Pharma Nonnarcotic Analgesics Product Portfolio
6.3.5 Atnahs Pharma Recent Developments/Updates
6.4 Baudax Bio
6.4.1 Baudax Bio Corporation Information
6.4.2 Baudax Bio Description and Business Overview
6.4.3 Baudax Bio Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Baudax Bio Nonnarcotic Analgesics Product Portfolio
6.4.5 Baudax Bio Recent Developments/Updates
6.5 Prestige Brands, Inc.
6.5.1 Prestige Brands, Inc. Corporation Information
6.5.2 Prestige Brands, Inc. Description and Business Overview
6.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Product Portfolio
6.5.5 Prestige Brands, Inc. Recent Developments/Updates
6.6 Cumberland Pharmaceuticals, Inc.
6.6.1 Cumberland Pharmaceuticals, Inc. Corporation Information
6.6.2 Cumberland Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Portfolio
6.6.5 Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Takeda Pharmaceutical Company
6.6.1 Takeda Pharmaceutical Company Corporation Information
6.6.2 Takeda Pharmaceutical Company Description and Business Overview
6.6.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Product Portfolio
6.7.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.8 Pfizer Inc.
6.8.1 Pfizer Inc. Corporation Information
6.8.2 Pfizer Inc. Description and Business Overview
6.8.3 Pfizer Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Pfizer Inc. Nonnarcotic Analgesics Product Portfolio
6.8.5 Pfizer Inc. Recent Developments/Updates
6.9 McNeil Consumer Healthcare
6.9.1 McNeil Consumer Healthcare Corporation Information
6.9.2 McNeil Consumer Healthcare Description and Business Overview
6.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Product Portfolio
6.9.5 McNeil Consumer Healthcare Recent Developments/Updates
6.10 Eli Lilly and Company
6.10.1 Eli Lilly and Company Corporation Information
6.10.2 Eli Lilly and Company Description and Business Overview
6.10.3 Eli Lilly and Company Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Eli Lilly and Company Nonnarcotic Analgesics Product Portfolio
6.10.5 Eli Lilly and Company Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Nonnarcotic Analgesics Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 Validus Pharmaceuticals
6.12.1 Validus Pharmaceuticals Corporation Information
6.12.2 Validus Pharmaceuticals Nonnarcotic Analgesics Description and Business Overview
6.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Product Portfolio
6.12.5 Validus Pharmaceuticals Recent Developments/Updates
6.13 Novartis Consumer Health
6.13.1 Novartis Consumer Health Corporation Information
6.13.2 Novartis Consumer Health Nonnarcotic Analgesics Description and Business Overview
6.13.3 Novartis Consumer Health Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Novartis Consumer Health Nonnarcotic Analgesics Product Portfolio
6.13.5 Novartis Consumer Health Recent Developments/Updates
6.14 Pacira Pharmaceuticals, Inc.
6.14.1 Pacira Pharmaceuticals, Inc. Corporation Information
6.14.2 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Description and Business Overview
6.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Portfolio
6.14.5 Pacira Pharmaceuticals, Inc. Recent Developments/Updates
6.15 Almatica Pharma
6.15.1 Almatica Pharma Corporation Information
6.15.2 Almatica Pharma Nonnarcotic Analgesics Description and Business Overview
6.15.3 Almatica Pharma Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Almatica Pharma Nonnarcotic Analgesics Product Portfolio
6.15.5 Almatica Pharma Recent Developments/Updates
6.16 BioDelivery Sciences International, Inc.
6.16.1 BioDelivery Sciences International, Inc. Corporation Information
6.16.2 BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Description and Business Overview
6.16.3 BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.16.4 BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Product Portfolio
6.16.5 BioDelivery Sciences International, Inc. Recent Developments/Updates
6.17 Akron, Inc.
6.17.1 Akron, Inc. Corporation Information
6.17.2 Akron, Inc. Nonnarcotic Analgesics Description and Business Overview
6.17.3 Akron, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Akron, Inc. Nonnarcotic Analgesics Product Portfolio
6.17.5 Akron, Inc. Recent Developments/Updates
6.18 Teva Pharmaceuticals, Inc.
6.18.1 Teva Pharmaceuticals, Inc. Corporation Information
6.18.2 Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Description and Business Overview
6.18.3 Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Portfolio
6.18.5 Teva Pharmaceuticals, Inc. Recent Developments/Updates
6.19 Heron Therapeutics
6.19.1 Heron Therapeutics Corporation Information
6.19.2 Heron Therapeutics Nonnarcotic Analgesics Description and Business Overview
6.19.3 Heron Therapeutics Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Heron Therapeutics Nonnarcotic Analgesics Product Portfolio
6.19.5 Heron Therapeutics Recent Developments/Updates
6.20 Assertio Therapeutics, Inc.
6.20.1 Assertio Therapeutics, Inc. Corporation Information
6.20.2 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Description and Business Overview
6.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product Portfolio
6.20.5 Assertio Therapeutics, Inc. Recent Developments/Updates
6.21 Sanofi s.A.
6.21.1 Sanofi s.A. Corporation Information
6.21.2 Sanofi s.A. Nonnarcotic Analgesics Description and Business Overview
6.21.3 Sanofi s.A. Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Sanofi s.A. Nonnarcotic Analgesics Product Portfolio
6.21.5 Sanofi s.A. Recent Developments/Updates
6.22 Endo Pharmaceuticals
6.22.1 Endo Pharmaceuticals Corporation Information
6.22.2 Endo Pharmaceuticals Nonnarcotic Analgesics Description and Business Overview
6.22.3 Endo Pharmaceuticals Nonnarcotic Analgesics Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Endo Pharmaceuticals Nonnarcotic Analgesics Product Portfolio
6.22.5 Endo Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nonnarcotic Analgesics Industry Chain Analysis
7.2 Nonnarcotic Analgesics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nonnarcotic Analgesics Production Mode & Process
7.4 Nonnarcotic Analgesics Sales and Marketing
7.4.1 Nonnarcotic Analgesics Sales Channels
7.4.2 Nonnarcotic Analgesics Distributors
7.5 Nonnarcotic Analgesics Customers
8 Nonnarcotic Analgesics Market Dynamics
8.1 Nonnarcotic Analgesics Industry Trends
8.2 Nonnarcotic Analgesics Market Drivers
8.3 Nonnarcotic Analgesics Market Challenges
8.4 Nonnarcotic Analgesics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nonnarcotic Analgesics Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nonnarcotic Analgesics Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nonnarcotic Analgesics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nonnarcotic Analgesics Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nonnarcotic Analgesics Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nonnarcotic Analgesics Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nonnarcotic Analgesics Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nonnarcotic Analgesics Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nonnarcotic Analgesics, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nonnarcotic Analgesics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nonnarcotic Analgesics, Product Type & Application
Table 12. Global Key Manufacturers of Nonnarcotic Analgesics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nonnarcotic Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonnarcotic Analgesics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nonnarcotic Analgesics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nonnarcotic Analgesics Sales by Region (2018-2024) & (K Units)
Table 18. Global Nonnarcotic Analgesics Sales Market Share by Region (2018-2024)
Table 19. Global Nonnarcotic Analgesics Sales by Region (2024-2029) & (K Units)
Table 20. Global Nonnarcotic Analgesics Sales Market Share by Region (2024-2029)
Table 21. Global Nonnarcotic Analgesics Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nonnarcotic Analgesics Revenue Market Share by Region (2018-2024)
Table 23. Global Nonnarcotic Analgesics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nonnarcotic Analgesics Revenue Market Share by Region (2024-2029)
Table 25. North America Nonnarcotic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 27. North America Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 28. North America Nonnarcotic Analgesics Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nonnarcotic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nonnarcotic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nonnarcotic Analgesics Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nonnarcotic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nonnarcotic Analgesics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nonnarcotic Analgesics Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nonnarcotic Analgesics Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nonnarcotic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nonnarcotic Analgesics Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nonnarcotic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nonnarcotic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nonnarcotic Analgesics Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nonnarcotic Analgesics Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nonnarcotic Analgesics Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nonnarcotic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nonnarcotic Analgesics Sales (K Units) by Type (2018-2024)
Table 51. Global Nonnarcotic Analgesics Sales (K Units) by Type (2024-2029)
Table 52. Global Nonnarcotic Analgesics Sales Market Share by Type (2018-2024)
Table 53. Global Nonnarcotic Analgesics Sales Market Share by Type (2024-2029)
Table 54. Global Nonnarcotic Analgesics Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nonnarcotic Analgesics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nonnarcotic Analgesics Revenue Market Share by Type (2018-2024)
Table 57. Global Nonnarcotic Analgesics Revenue Market Share by Type (2024-2029)
Table 58. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nonnarcotic Analgesics Sales (K Units) by Application (2018-2024)
Table 61. Global Nonnarcotic Analgesics Sales (K Units) by Application (2024-2029)
Table 62. Global Nonnarcotic Analgesics Sales Market Share by Application (2018-2024)
Table 63. Global Nonnarcotic Analgesics Sales Market Share by Application (2024-2029)
Table 64. Global Nonnarcotic Analgesics Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nonnarcotic Analgesics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nonnarcotic Analgesics Revenue Market Share by Application (2018-2024)
Table 67. Global Nonnarcotic Analgesics Revenue Market Share by Application (2024-2029)
Table 68. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2024-2029)
Table 70. GlaxoSmithKline Consumer Healthcare Corporation Information
Table 71. GlaxoSmithKline Consumer Healthcare Description and Business Overview
Table 72. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product
Table 74. GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
Table 75. Bayer Corporation Corporation Information
Table 76. Bayer Corporation Description and Business Overview
Table 77. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Bayer Corporation Nonnarcotic Analgesics Product
Table 79. Bayer Corporation Recent Developments/Updates
Table 80. Atnahs Pharma Corporation Information
Table 81. Atnahs Pharma Description and Business Overview
Table 82. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Atnahs Pharma Nonnarcotic Analgesics Product
Table 84. Atnahs Pharma Recent Developments/Updates
Table 85. Baudax Bio Corporation Information
Table 86. Baudax Bio Description and Business Overview
Table 87. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Baudax Bio Nonnarcotic Analgesics Product
Table 89. Baudax Bio Recent Developments/Updates
Table 90. Prestige Brands, Inc. Corporation Information
Table 91. Prestige Brands, Inc. Description and Business Overview
Table 92. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Prestige Brands, Inc. Nonnarcotic Analgesics Product
Table 94. Prestige Brands, Inc. Recent Developments/Updates
Table 95. Cumberland Pharmaceuticals, Inc. Corporation Information
Table 96. Cumberland Pharmaceuticals, Inc. Description and Business Overview
Table 97. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 99. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Takeda Pharmaceutical Company Corporation Information
Table 101. Takeda Pharmaceutical Company Description and Business Overview
Table 102. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product
Table 104. Takeda Pharmaceutical Company Recent Developments/Updates
Table 105. Pfizer Inc. Corporation Information
Table 106. Pfizer Inc. Description and Business Overview
Table 107. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Pfizer Inc. Nonnarcotic Analgesics Product
Table 109. Pfizer Inc. Recent Developments/Updates
Table 110. McNeil Consumer Healthcare Corporation Information
Table 111. McNeil Consumer Healthcare Description and Business Overview
Table 112. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. McNeil Consumer Healthcare Nonnarcotic Analgesics Product
Table 114. McNeil Consumer Healthcare Recent Developments/Updates
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Eli Lilly and Company Nonnarcotic Analgesics Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Corporation Information
Table 121. Sun Pharmaceutical Industries Description and Business Overview
Table 122. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product
Table 124. Sun Pharmaceutical Industries Recent Developments/Updates
Table 125. Validus Pharmaceuticals Corporation Information
Table 126. Validus Pharmaceuticals Description and Business Overview
Table 127. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Validus Pharmaceuticals Nonnarcotic Analgesics Product
Table 129. Validus Pharmaceuticals Recent Developments/Updates
Table 130. Novartis Consumer Health Corporation Information
Table 131. Novartis Consumer Health Description and Business Overview
Table 132. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Novartis Consumer Health Nonnarcotic Analgesics Product
Table 134. Novartis Consumer Health Recent Developments/Updates
Table 135. Pacira Pharmaceuticals, Inc. Corporation Information
Table 136. Pacira Pharmaceuticals, Inc. Description and Business Overview
Table 137. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 139. Pacira Pharmaceuticals, Inc. Recent Developments/Updates
Table 140. Almatica Pharma Corporation Information
Table 141. Almatica Pharma Description and Business Overview
Table 142. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Almatica Pharma Nonnarcotic Analgesics Product
Table 144. Almatica Pharma Recent Developments/Updates
Table 145. BioDelivery Sciences International, Inc. Corporation Information
Table 146. BioDelivery Sciences International, Inc. Description and Business Overview
Table 147. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Product
Table 149. BioDelivery Sciences International, Inc. Recent Developments/Updates
Table 150. Akron, Inc. Corporation Information
Table 151. Akron, Inc. Description and Business Overview
Table 152. Akron, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Akron, Inc. Nonnarcotic Analgesics Product
Table 154. Akron, Inc. Recent Developments/Updates
Table 155. Teva Pharmaceuticals, Inc. Corporation Information
Table 156. Teva Pharmaceuticals, Inc. Description and Business Overview
Table 157. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 159. Teva Pharmaceuticals, Inc. Recent Developments/Updates
Table 160. Heron Therapeutics Corporation Information
Table 161. Heron Therapeutics Description and Business Overview
Table 162. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Heron Therapeutics Nonnarcotic Analgesics Product
Table 164. Heron Therapeutics Recent Developments/Updates
Table 165. Assertio Therapeutics, Inc. Corporation Information
Table 166. Assertio Therapeutics, Inc. Description and Business Overview
Table 167. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product
Table 169. Assertio Therapeutics, Inc. Recent Developments/Updates
Table 170. Sanofi s.A. Corporation Information
Table 171. Sanofi s.A. Description and Business Overview
Table 172. Sanofi s.A. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Sanofi s.A. Nonnarcotic Analgesics Product
Table 174. Sanofi s.A. Recent Developments/Updates
Table 175. Endo Pharmaceuticals Corporation Information
Table 176. Endo Pharmaceuticals Description and Business Overview
Table 177. Endo Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Endo Pharmaceuticals Nonnarcotic Analgesics Product
Table 179. Endo Pharmaceuticals Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Nonnarcotic Analgesics Distributors List
Table 183. Nonnarcotic Analgesics Customers List
Table 184. Nonnarcotic Analgesics Market Trends
Table 185. Nonnarcotic Analgesics Market Drivers
Table 186. Nonnarcotic Analgesics Market Challenges
Table 187. Nonnarcotic Analgesics Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nonnarcotic Analgesics
Figure 2. Global Nonnarcotic Analgesics Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nonnarcotic Analgesics Market Share by Type in 2022 & 2029
Figure 4. Salicylates Product Picture
Figure 5. Anilines Product Picture
Figure 6. Pyrazolones Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nonnarcotic Analgesics Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Nonnarcotic Analgesics Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Specialist Clinic
Figure 13. Other
Figure 14. Global Nonnarcotic Analgesics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Nonnarcotic Analgesics Market Size (2018-2029) & (US$ Million)
Figure 16. Global Nonnarcotic Analgesics Sales (2018-2029) & (K Units)
Figure 17. Global Nonnarcotic Analgesics Average Price (US$/Unit) & (2018-2029)
Figure 18. Nonnarcotic Analgesics Report Years Considered
Figure 19. Nonnarcotic Analgesics Sales Share by Manufacturers in 2022
Figure 20. Global Nonnarcotic Analgesics Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Nonnarcotic Analgesics Players: Market Share by Revenue in 2022
Figure 22. Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Nonnarcotic Analgesics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Nonnarcotic Analgesics Sales Market Share by Country (2018-2029)
Figure 25. North America Nonnarcotic Analgesics Revenue Market Share by Country (2018-2029)
Figure 26. United States Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Nonnarcotic Analgesics Sales Market Share by Country (2018-2029)
Figure 29. Europe Nonnarcotic Analgesics Revenue Market Share by Country (2018-2029)
Figure 30. Germany Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Nonnarcotic Analgesics Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Nonnarcotic Analgesics Revenue Market Share by Region (2018-2029)
Figure 37. China Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Nonnarcotic Analgesics Sales Market Share by Country (2018-2029)
Figure 47. Latin America Nonnarcotic Analgesics Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Nonnarcotic Analgesics Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Nonnarcotic Analgesics Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Nonnarcotic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Nonnarcotic Analgesics by Type (2018-2029)
Figure 57. Global Revenue Market Share of Nonnarcotic Analgesics by Type (2018-2029)
Figure 58. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Nonnarcotic Analgesics by Application (2018-2029)
Figure 60. Global Revenue Market Share of Nonnarcotic Analgesics by Application (2018-2029)
Figure 61. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2018-2029)
Figure 62. Nonnarcotic Analgesics Value Chain
Figure 63. Nonnarcotic Analgesics Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed